opana er oxymorphone hydrochloride 5 mg tablet film coated extended release
INDICATIONS AND USAGE OPANA ER is indicated for the relief of moderate to severe pain in patients requiring continuous, around-the-clock opioid treatment for an extended period of time. OPANA ER is not intended for use as a prn analgesic. OPANA ER is not indicated for pain in the immediate post-operative period (12-24 hours following surgery) for patients not previously taking opioids because of the risk of oversedation and respiratory depression requiring reversal with opioid antagonists. OPANA ER is not indicated for pain in the post-operative period if the pain is mild or not expected to persist for an extended period of time.
stat rx usa llc
OCTAGON PINK E907 5
Related Pills
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
HOW SUPPLIED OPANA ER tablets are supplied as follows: 5 mg pink, octagon shape, film coated, convex tablets with “E907” over “5” in black print on one side and plain on the other. Bottles of 100 with child-resistant closure NDC 63481-907-70 Unit-Dose package of 100 tablets (5 blister cards of 20 tablets, not child-resistant, for hospital use only) NDC 63481-907-75 10 mg Light orange, octagon shape, film coated, convex tablets with “E674” over “10” in black print on one side and plain on the other. Bottles of 100 with child-resistant closure NDC 63481-674-70 Unit-Dose package of 100 tablets (5 blister cards of 20 tablets, not child-resistant, for hospital use only) NDC 63481-674-75 20 mg Light green, octagon shape, film coated, convex tablets with “E617” over “20” in black print on one side and plain on the other. Bottles of 100 with child-resistant closure NDC 63481-617-70 Unit-Dose package of 100 tablets (5 blister cards of 20 tablets, not child-resistant, for hospital use only) NDC 63481-617-75 40 mg yellow, octagon shape, film coated, convex tablets with “E693” over “40” in black print on one side and plain on the other. Bottles of 100 with child-resistant closure NDC 63481-693-70 Unit-Dose package of 100 tablets (5 blister cards of 20 tablets, not child-resistant, for hospital use only) NDC 63481-693-75 Rx Only CAUTION DEA Order Form Required.
More pills like OCTAGON E907 5